Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02149485
Other study ID # 13-2010
Secondary ID
Status Recruiting
Phase N/A
First received May 20, 2014
Last updated January 13, 2017
Start date January 2014
Est. completion date December 2018

Study information

Verified date January 2017
Source Maastricht University Medical Center
Contact Christine de Die-Smulders, MD PhD
Phone +31 43 3875897
Email c.dedie@mumc.nl
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Since 1995, preimplantation genetic diagnosis (PGD) has been performed in The Netherlands for couples at high risk for transmitting severe or lethal genetic conditions or who have experienced multiple miscarriages due to chromosomal translocations. Approximately 260 children have been born after PGD in The Netherlands. Follow-up data on children born after PGD are scarce. Long-term studies on PGD children have not been conducted in The Netherlands. Results of studies in other countries on 2-year old PGD children are reassuring. These children and their parents have normal scores on relevant parameters such as general health, cognitive and socioemotional development, parent-child interaction and parental stress. Studies of good methodological quality of older children have not yet been published.

Objective: Long-term follow-up of children who have been born after PGD in The Netherlands. The primary aim is to assess the safety of PGD with regard to the health and development of the children.

Study design: A cohort study. Study population: 5- and 8 year old children born after PGD in The Netherlands for various indications and their parents. Control groups consist of 5 and 8-year old naturally conceived (NC) children of parents who have considered PGD treatment and 5 and 8-year old children born after in vitro fertilisation/intracytoplasmatic sperm injection (IVF/ICSI), and the parents of the two latter groups of children.


Description:

Parents are asked to fill out questionnaires on their own and their child's medical history. A physical examination of the children will be performed, a swab for collection of buccal cells for (future) DNA methylation analysis will be taken and their cognitive and socioemotional development will be assessed. In the 8 years old children cardiovascular status will be evaluated.

Main study parameters: general health, cognitive and socioemotional development, parent-child interaction and parental stress.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:

The study procedure consists of filling out questionnaires by parents and a one-time visit to the hospital. No invasive interventions will be performed, except 1 tube of blood in the 8 year old group. The risks associated with the study procedure are very small. The results provide more information about the risks of PGD to prospective parents who are considering PGD and to healthcare providers involved in PGD treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date December 2018
Est. primary completion date December 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 5 Years
Eligibility Inclusion criteria:

PGD children

- 5-year old singleton PGD children with Caucasian parents

- Children must have the Dutch language as their mother tongue for participation in the intelligence quotient (IQ) test. Children that do not have Dutch as their mother tongue will be excluded from the IQ test, but can take part in the rest of the procedure

Naturally conceived (NC) children

- 5-year old singleton NC children with Caucasian parents, matched with PGD children on age and sex

- Parents must have attended the PGD clinic in Maastricht for an informative consultation

- Parents must have become pregnant without any assisted reproductive technique

- Children must have the Dutch language as their mother tongue

IVF/ICSI children

- 5-year old singleton IVF/ICSI children with Caucasian parents, matched with PGD children on age and sex

- Children must have the Dutch language as their mother tongue

Exclusion criteria:

PGD children

- Twins or triplets

- Parents of non-Caucasian descent

- Children with known chromosomal abnormalities (e.g. trisomy 21) or gene disorders with childhood expression of symptoms

NC children

- Twins or triplets

- Parents of non-Caucasian descent

- Children with known chromosomal abnormalities or gene disorders with childhood expression of symptoms

IVF/ICSI children

- Twins or triplets

- Parents of non-Caucasian descent

- Children with known chromosomal abnormalities or gene disorders with childhood expression of symptoms

8 years old group Former participants of the study in 5 year old children

Study Design


Related Conditions & MeSH terms

  • Preimplantation Genetic Diagnosis

Locations

Country Name City State
Netherlands Maastricht University Hospital Maastricht Limburg
Netherlands University Medical Center Utrecht Utrecht

Sponsors (1)

Lead Sponsor Collaborator
Maastricht University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physical health of 5 years old children born after preimplantation genetic diagnosis Physical health of 5 and 8 years old children born after PGD will be assessed by physical examination and measurement of height, weight and compared with children born after IVF/ICSI and naturally conceived children. 5 years
Secondary Psychological health of 5 and 8 years old children born after preimplantation genetic diagnosis Psychological health will be assesses by neuropsychological testing, and questionaires 5 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT01336400 - Genome-wide Single Cell Haplotyping as a Generic Method for Preimplantation Genetic Diagnosis N/A
Recruiting NCT03758833 - eSET or eDET Associated to PGT in IVF N/A
Completed NCT04584047 - Cell Based Non Invasive Prenatal Testing as an Alternative to Chorionic Villus Sampling Following Preimplantation Genetic Testing N/A